The burden and epidemiology of anaerobic bacteraemia: a retrospective multi-centre multi- national cross-sectional study (CROSBI ID 729786)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Join-Lambert, O ; Guet-Revillet, H ; Dumont, Y ; Justesen, U ; Boyer, P ; Morris, T ; Pranada, A ; Rompf, C ; Pierard, D ; Wybo, I ; Novak, Anita ; Riverain Gillet, E ; Cobo Martínez, F ; Jean- Pierre, H ; Malandain, D ; Antonini, L ; Sóki, J ; Gajdacs, M ; Baaity, Z ; Jamal, W ; Veloo, L ; Cordovana, M, Ambretti, S ; Assous, M ; Safarika, A ; Giannistisioti, E ; Nurver, U ; Verdon, R ; Le Hello, S ; Parienti, JJ
ESGAI
engleski
The burden and epidemiology of anaerobic bacteraemia: a retrospective multi-centre multi- national cross-sectional study
The burden of anaerobic bacteremia ranged from 2 to 14% of patients with positive BCs among centers, reflecting different hospital sizes and medical activities. Cutibacterium acnes was the most frequently recovered anaerobe in some centers, suggesting different medical activities / BCs laboratory procedures. Antimicrobial resistance rate in the B. fragilis group is worrisome. It may be associated with treatment failures and requires continuous surveillance.
anaerobes, ESGAI, resistance, anaerobic bacteraemia
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
/-/.
2021.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019)
predavanje
09.07.2021-12.07.2021
Beč, Austrija
